Huang, S.-F.; Chong, S.-W.; Huang, C.-W.; Hsu, H.-Y.; Pan, K.-T.; Hung, C.-F.; Wu, T.-H.; Lee, C.-W.; Hsieh, C.-H.; Wang, C.-T.;
et al. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines 2022, 10, 2277.
https://doi.org/10.3390/biomedicines10092277
AMA Style
Huang S-F, Chong S-W, Huang C-W, Hsu H-Y, Pan K-T, Hung C-F, Wu T-H, Lee C-W, Hsieh C-H, Wang C-T,
et al. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines. 2022; 10(9):2277.
https://doi.org/10.3390/biomedicines10092277
Chicago/Turabian Style
Huang, Song-Fong, Sio-Wai Chong, Chun-Wei Huang, Heng-Yuan Hsu, Kuang-Tse Pan, Chien-Fu Hung, Tsung-Han Wu, Chao-Wei Lee, Chia-Hsun Hsieh, Ching-Ting Wang,
and et al. 2022. "Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma" Biomedicines 10, no. 9: 2277.
https://doi.org/10.3390/biomedicines10092277
APA Style
Huang, S.-F., Chong, S.-W., Huang, C.-W., Hsu, H.-Y., Pan, K.-T., Hung, C.-F., Wu, T.-H., Lee, C.-W., Hsieh, C.-H., Wang, C.-T., Chai, P.-M., & Yu, M.-C.
(2022). Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma. Biomedicines, 10(9), 2277.
https://doi.org/10.3390/biomedicines10092277
